Beauty Health - Public Comps and Valuation Multiples

Beauty Health Overview

About Beauty Health

The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.

Founded

2020

HQ

Employees

769

Website

beautyhealth.com

Sectors

Health & Beauty

Financials

LTM Revenue $299M

LTM EBITDA $35.8M

EV

$362M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Beauty Health Financials

As of November 2025, Beauty Health reported last 12-month revenue of $299M and EBITDA of $35.8M.

In the same period, Beauty Health generated $195M in LTM gross profit and -$9.0M in net income.

See Beauty Health valuation multiples based on analyst estimates

Beauty Health P&L

In the most recent fiscal year, Beauty Health reported revenue of $334M and EBITDA of $14.5M.

Beauty Health expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Beauty Health valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$299M	XXX	$334M	XXX	XXX	XXX
Gross Profit	$195M	XXX	$182M	XXX	XXX	XXX
Gross Margin	65%	XXX	55%	XXX	XXX	XXX
EBITDA	$35.8M	XXX	$14.5M	XXX	XXX	XXX
EBITDA Margin	12%	XXX	4%	XXX	XXX	XXX
EBIT	-$9.6M	XXX	-$67.8M	XXX	XXX	XXX
EBIT Margin	-3%	XXX	-20%	XXX	XXX	XXX
Net Profit	-$9.0M	XXX	-$29.1M	XXX	XXX	XXX
Net Margin	-3%	XXX	-9%	XXX	XXX	XXX
Net Debt	XXX	XXX	$182M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Beauty Health including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $299M. EBITDA for the last twelve months was $35.8M. In the most recent fiscal year, Beauty Health achieved $334M in revenue and $14.5M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$299M	Analyst estimates available to subscribers	$334M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$195M	Analyst estimates available to subscribers	$182M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	65.3% gross margin	Analyst estimates available to subscribers	54.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$35.8M	Analyst estimates available to subscribers	$14.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	12.0% EBITDA margin	Analyst estimates available to subscribers	4.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$9.6M	Analyst estimates available to subscribers	-$67.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-3.2% EBIT margin	Analyst estimates available to subscribers	-20.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$9.0M	Analyst estimates available to subscribers	-$29.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-3.0% net profit margin	Analyst estimates available to subscribers	-8.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$182M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Beauty Health

This financial data table provides comprehensive performance metrics for Beauty Health, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Beauty Health generated $299M in revenue over the last twelve months.
The company achieved $35.8M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $195M.
Net income over the last twelve months reached -$9.0M.

Fiscal Year Performance

In the most recent fiscal year, Beauty Health reported $334M in total revenue.
Fiscal year EBITDA was $14.5M.
The company maintained a gross profit margin of 54.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 4.4%.
Net profit margin reached -8.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Beauty Health. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Beauty Health Stock Performance

Beauty Health has current market cap of $203M, and EV of $362M.

Market Cap Evolution

Beauty Health Stock Data

As of December 5, 2025, Beauty Health's stock price is $2.

See Beauty Health trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$362M	$203M	XXX	XXX	XXX	XXX	$-0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Beauty Health Valuation Multiples

Beauty Health's trades at 1.1x EV/Revenue multiple, and 24.9x EV/EBITDA.

See valuation multiples for Beauty Health and 15K+ public comps

Beauty Health Financial Valuation Multiples

As of December 5, 2025, Beauty Health has market cap of $203M and EV of $362M.

Equity research analysts estimate Beauty Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Beauty Health has a P/E ratio of -22.5x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$203M	XXX	$203M	XXX	XXX	XXX
EV (current)	$362M	XXX	$362M	XXX	XXX	XXX
EV/Revenue	1.2x	XXX	1.1x	XXX	XXX	XXX
EV/EBITDA	10.1x	XXX	24.9x	XXX	XXX	XXX
EV/EBIT	-37.9x	XXX	-5.3x	XXX	XXX	XXX
EV/Gross Profit	1.9x	XXX	n/a	XXX	XXX	XXX
P/E	-22.5x	XXX	-7.0x	XXX	XXX	XXX
EV/FCF	14.6x	XXX	38.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Beauty Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Beauty Health Margins & Growth Rates

Beauty Health's last 12 month revenue growth is 3%

Beauty Health's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.

Beauty Health's rule of 40 is -10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Beauty Health's rule of X is 20% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Beauty Health and other 15K+ public comps

Beauty Health Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	3%	XXX	-4%	XXX	XXX	XXX
EBITDA Margin	12%	XXX	4%	XXX	XXX	XXX
EBITDA Growth	0%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-10%	XXX	8%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	20%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.4M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	35%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	75%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial